Open: 3:11 PM
BioLineRx Stock Price Graph
BioLineRx Stock Price Today
BioLineRx Ltd. (BLRX) stock rallied over 4.83% intraday to trade at $1.52 a share on NASDAQ. The stock opened with a loss of -7.59% at $1.34 and touched an intraday high of $1.36, rising 4.83% against the last close of $1.45. The BioLineRx Ltd. in stock market went to a low of $1.25 during the session.
BioLineRx Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
BioLineRx Stock Price History Chart
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in patients with acute respiratory distress syndrome secondary to COVID-19 and other respiratory viral infections, as well as for the treatment of solid tumors and acute myeloid leukemia. It is also developing AGI-134, an immuno-oncology agent, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The company has collaboration agreement with MSD for the cancer immunotherapy field; MD Anderson Cancer Center to investigate the combination of Motixafortide with KEYTRUDA (pembrolizumab) in pancreatic cancer; and licensing arrangement with Perrigo Company plc for over-the-counter sale of BL-5010. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Frequently Asked Questions
What is the current BioLineRx Ltd. (BLRX) stock price?
BioLineRx Ltd. (NASDAQ: BLRX) stock price is $1.52 in the last trading session. During the trading session, BLRX stock reached the peak price of $1.36 while $1.25 was the lowest point it dropped to. The percentage change in BLRX stock occurred in the recent session was 4.83% while the dollar amount for the price change in BLRX stock was $0.07.
BLRX's industry and sector of operation?
The NASDAQ listed BLRX is part of Biotechnology industry that operates in the broader Healthcare sector. BioLineRx Ltd. , a clinical-stage biopharmaceutical development company, focuses on oncology.
Who are the executives of BLRX?
Advocate Norman Kotler
Internal Enforcement Officer, Gen. Counsel and Corporation Sec.
Mr. John Lacey
Head of Corporation Communications & Investor Relations
Ms. Liron Shemesh-Darvish M.B.A., Ph.D.
Senior Director & Head of Preclinical Devel.
Ms. Jael Birenberg M.Sc.
Senior Director & Head of RA, QA and PhV
How BLRX did perform over past 52-week?
BLRX's closing price is 1.13% higher than its 52-week low of $0.55 where as its distance from 52-week high of $2.53 is -0.41%.
How many employees does BLRX have?
Number of BLRX employees currently stands at N/A. BLRX operates from Modi’in Technology Park, Hevel Modi'in, 7177871, IL.
Link for BLRX official website?
Official Website of BLRX is: https://www.biolinerx.com
How do I contact BLRX?
How many shares of BLRX are traded daily?
BLRX stock volume for the day was 190170.00 shares. The average number of BLRX shares traded daily for last 3 months was 1.12 Million.
What is the market cap of BLRX currently?
The market value of BLRX currently stands at $109.76 Million with its latest stock price at $1.52 and N/A of its shares outstanding.